In a recent paper, high throughput proteomic analysis on more than 550 newly diagnosed AML patients demonstrated that high plasma concentration of soluble OSMR protein was a strong independent predictor of poor survival and early mortality (20). This evidence concerns the gene OSMR and acute myeloid leukemia.